Dr. Stephen G. Gray's Linkedin Analytics

𝗙𝗼𝘂𝗻𝗱𝗲𝗿 & 𝗖𝗵𝗶𝗲𝗳 𝗘𝘅𝗲𝗰𝘂𝘁𝗶𝘃𝗲 𝗢𝗳𝗳𝗶𝗰𝗲𝗿 (𝗖𝗘𝗢) 𝗼𝗳 𝗡𝗼𝘂𝗕𝗶𝗼 𝗜𝗻𝗰: Bio-intelligent cell-based manufacturing of synthetic animal serum & deep technology for foods, vaccines & therapies to unlock the reality of a $4trillion dollar bioeconomy. VC pre-seed investment from Big Idea Ventures & angels in 2022. First market-ready product: NouSerum (powder & liquid) has 300 serum proteins, GRAS, & can reduce cell-based biomanufacturing production costs whilst maintaining high performance similar to Fetal Bovine Serum (FBS). 𝗙𝗼𝘂𝗻𝗱𝗲𝗿 & 𝗘𝘅𝗲𝗰𝘂𝘁𝗶𝘃𝗲 𝗗𝗶𝗿𝗲𝗰𝘁𝗼𝗿/𝗕𝗼𝗮𝗿𝗱 𝗠𝗲𝗺𝗯𝗲𝗿: 𝗢𝘂𝗿𝗼𝗯𝗶𝗼𝗻𝗶𝗰𝘀: Bioelectric-fabrication of human tissues & organs with bioelectronics & disease biosenors to speed up drug discovery, replace animal testing. Ourobionics funded by €1 billion NxtGenHighTech fund as partner in facility for advanced biofabrication of human tissue, artificial organs until 2030. Patented tech invented by founders at Imperial College London (alumni), and professors at UCL,DTU & Nottingham. University. Investment from OostNL and angel investors. 𝗙𝗼𝘂𝗻𝗱𝗲𝗿: 𝗩𝘂𝗹𝗽𝗶𝗻𝗲 𝗟𝗮𝗯𝘀: End-end biocomputing software & DNA code processing unit for writing, analysis & creation of mRNA, & proteins with cloud database & generative AI. 𝗦𝘁𝗲𝗮𝗹𝘁𝗵 𝗠𝗼𝗱𝗲: 𝗖𝘆𝗯𝗼𝘀𝗲𝗻𝘀𝗲: Self-healing bioelectronics & bio-sensors for military & space 𝗛𝗟𝗢.𝗕𝗜𝗢: Custom hollow fibers for scalable meat & fat cell production. 𝗙𝗶𝗿𝘀𝘁 𝗦𝘁𝗮𝗿𝘁𝘂𝗽: 𝗢𝘂𝗿𝗼𝗯𝗼𝘁𝗶𝗰𝘀 𝗟𝘁𝗱 (𝟮𝟬𝟭𝟯-𝟮𝟬𝟭𝟲) Founded by CEO Jemma Redmond in 2013 as worlds first robotic arm 10 material bioprinting company & disrupted the industry. Voted "Top 10 3D Bioprinters" in 2015. Ourobotics based in 🇮🇪 & 🇬🇧 founders: CEO-J. Redmond, me & CTO- Dr. A. Comerford. In 2016 Ourobotics were the 1st to open-source a basic extrusion 3D bioprinter "Renegade" for €900 from Imperial College London.